Fig. 5From: Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancerFunctional analysis of human colon cancer cell lines treated with KPNA2 shRNA. KPNA2 knockdown inhibits colon cancer cell a-b growth (*P < 0.05), c colony formation (*P < 0.05) and d invasion (***P < 0.01). CON: blank control group; NC: negative control group; KD1: KPNA2 shRNA1; KD2: KPNA2 shRNA2Back to article page